Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q2 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $980 thousand versus the consensus estimate of $1.22 million.
For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
